6King H,Aubert RE,Herman WH.Global burden of diabetes,1995-2025:prevalence,numerical estimates,and projections.Diabetes Care,1998,21:1414-1431.
7Stovring H,Andersen M,Beck-Nielsen H,et al.Rising prevalence of diabetes:evidence from a Danish pharmacy-epidemiolngical database.Lancet,2003,362:537-538.
8Silverman DT,Schiffman M,Everhart J,et al.Diabetes mellitus,other medical conditions and familial history of cancer as risk factors for pancreatic cancer.Br J Cancer,1999,80:1830-1837.
9Yang YX,Hennessy S,Lewis JD.Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.Gastroenterology,2004,127:1044-1050.
10Bayram A,Eksi F,Mehli M.Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.Gastroenterology,2008,134:95-101.
1Faurholt-Jepsen D, Range N, PrayGod G, et al. The role of diabetes on the clinical manifestations of pulmonary tuberculosis [J]. Trop Med Int Health, 2012, 17 (7) : 877- 883.
2Hu HY, Wu CY, Huang N, et al. Increased risk of tuberculosis in patients with end-stage renal disease., a population-based co-hort study in Taiwan, a country of high incidence of end-stage renal disease[J], Epidemiol Infect, 2014, 142(1) :191 - 199.
3Mendoza-Aguilar M, Garcia-Elorriaga G, Arce-Paredes P, et al. Functional state analysis of phagocytic cells of patients with type 2 diabetes and pulmonary tuberculosis [J]. Clin Lab, 2012, 58 (3-4): 299-305.
4Gomes T, Reis-Santos B, Bertolde A, et al. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model [J]. BMCInfectDis, 2014, 14: 9.
